258 related articles for article (PubMed ID: 28549887)
1. Fluvoxamine maleate effects on dopamine signaling in the prefrontal cortex of stressed Parkinsonian rats: Implications for learning and memory.
Dallé E; Daniels WMU; Mabandla MV
Brain Res Bull; 2017 Jun; 132():75-81. PubMed ID: 28549887
[TBL] [Abstract][Full Text] [Related]
2. Anti-parkinsonian effects of fluvoxamine maleate in maternally separated rats.
Dallé E; Daniels WMU; Mabandla MV
Int J Dev Neurosci; 2016 Oct; 53():26-34. PubMed ID: 27338206
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effect of etazolate on depression-like behavior and, learning, and memory impairment in a model of Parkinson's disease.
Alzoubi KH; Mokhemer E; Abuirmeileh AN
Behav Brain Res; 2018 Sep; 350():109-115. PubMed ID: 29758248
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Treatment with Fluvoxamine Decreases Nonmotor Symptoms and Dopamine Depletion in a Postnatal Stress Rat Model of Parkinson's Disease.
Dallé E; Daniels WMU; Mabandla MV
Oxid Med Cell Longev; 2020; 2020():1941480. PubMed ID: 32273939
[TBL] [Abstract][Full Text] [Related]
5. Fluvoxamine maleate normalizes striatal neuronal inflammatory cytokine activity in a Parkinsonian rat model associated with depression.
Dallé E; Daniels WM; Mabandla MV
Behav Brain Res; 2017 Jan; 316():189-196. PubMed ID: 27569183
[TBL] [Abstract][Full Text] [Related]
6. Activation and blockade of serotonin
Guo Y; Zhang L; Zhang J; Du CX; Lv SX; Wang T; Wang HS; Xie W; Liu J
Neurol Res; 2019 Jul; 41(7):585-593. PubMed ID: 30929589
[No Abstract] [Full Text] [Related]
7. L-DOPA-induced dysregulation of extrastriatal dopamine and serotonin and affective symptoms in a bilateral rat model of Parkinson's disease.
Eskow Jaunarajs KL; George JA; Bishop C
Neuroscience; 2012 Aug; 218():243-56. PubMed ID: 22659568
[TBL] [Abstract][Full Text] [Related]
8. 6-Hydroxydopamine-Induced Dopamine Reductions in the Nucleus Accumbens, but not the Medial Prefrontal Cortex, Impair Cincinnati Water Maze Egocentric and Morris Water Maze Allocentric Navigation in Male Sprague-Dawley Rats.
Braun AA; Amos-Kroohs RM; Gutierrez A; Lundgren KH; Seroogy KB; Vorhees CV; Williams MT
Neurotox Res; 2016 Aug; 30(2):199-212. PubMed ID: 27003940
[TBL] [Abstract][Full Text] [Related]
9. Lesions of the lateral habenula improve working memory performance in hemiparkinsonian rats.
Du CX; Liu J; Guo Y; Zhang L; Zhang QJ
Neurosci Lett; 2018 Jan; 662():162-166. PubMed ID: 29054431
[TBL] [Abstract][Full Text] [Related]
10. Activation and blockade of serotonin
Liu KC; Li JY; Xie W; Li LB; Zhang J; Du CX; Zhang YM; Tan HH; Wang HS; Zhang L
Brain Res; 2016 Nov; 1650():184-195. PubMed ID: 27616337
[TBL] [Abstract][Full Text] [Related]
11. Sulpiride in combination with fluvoxamine increases in vivo dopamine release selectively in rat prefrontal cortex.
Ago Y; Nakamura S; Baba A; Matsuda T
Neuropsychopharmacology; 2005 Jan; 30(1):43-51. PubMed ID: 15383832
[TBL] [Abstract][Full Text] [Related]
12. Involvement of prelimbic 5-HT
Du CX; Guo Y; Zhang QJ; Zhang J; Lv SX; Liu J
Neurol Res; 2018 Oct; 40(10):847-855. PubMed ID: 29989483
[TBL] [Abstract][Full Text] [Related]
13. The effect of the alpha2-adrenoreceptor antagonist idazoxan against 6-hydroxydopamine-induced Parkinsonism in rats: multiple facets of action?
Srinivasan J; Schmidt WJ
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jun; 369(6):629-38. PubMed ID: 15118809
[TBL] [Abstract][Full Text] [Related]
14. Nitrosative and cognitive effects of chronic L-DOPA administration in rats with intra-nigral 6-OHDA lesion.
Ramírez-García G; Palafox-Sánchez V; Limón ID
Neuroscience; 2015 Apr; 290():492-508. PubMed ID: 25644418
[TBL] [Abstract][Full Text] [Related]
15. Synergistic dopamine increase in the rat prefrontal cortex with the combination of quetiapine and fluvoxamine.
Denys D; Klompmakers AA; Westenberg HG
Psychopharmacology (Berl); 2004 Nov; 176(2):195-203. PubMed ID: 15138756
[TBL] [Abstract][Full Text] [Related]
16. Role of Cyclooxygenase Inhibitors in Diminution of Dissimilar Stress-induced Depressive Behavior and Memory Impairment in Rats.
Perveen T; Emad S; Haider S; Sadaf S; Qadeer S; Batool Z; Sarfaraz Y; Sheikh S
Neuroscience; 2018 Feb; 370():121-129. PubMed ID: 29141189
[TBL] [Abstract][Full Text] [Related]
17. Decreased synaptic plasticity in the medial prefrontal cortex underlies short-term memory deficits in 6-OHDA-lesioned rats.
Matheus FC; Rial D; Real JI; Lemos C; Ben J; Guaita GO; Pita IR; Sequeira AC; Pereira FC; Walz R; Takahashi RN; Bertoglio LJ; Da Cunha C; Cunha RA; Prediger RD
Behav Brain Res; 2016 Mar; 301():43-54. PubMed ID: 26707254
[TBL] [Abstract][Full Text] [Related]
18. The NMDA glycine site antagonist (+)-HA-966 selectively regulates conditioned stress-induced metabolic activation of the mesoprefrontal cortical dopamine but not serotonin systems: a behavioral, neuroendocrine, and neurochemical study in the rat.
Goldstein LE; Rasmusson AM; Bunney BS; Roth RH
J Neurosci; 1994 Aug; 14(8):4937-50. PubMed ID: 8046462
[TBL] [Abstract][Full Text] [Related]
19. Effects of the adenosine A2A antagonist istradefylline on cognitive performance in rats with a 6-OHDA lesion in prefrontal cortex.
Kadowaki Horita T; Kobayashi M; Mori A; Jenner P; Kanda T
Psychopharmacology (Berl); 2013 Dec; 230(3):345-52. PubMed ID: 23748382
[TBL] [Abstract][Full Text] [Related]
20. In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine.
Jordan S; Kramer GL; Zukas PK; Moeller M; Petty F
Synapse; 1994 Dec; 18(4):294-7. PubMed ID: 7886621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
